---
title: "Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101"
date: "2025-09-11T04:00:00.000Z"
publishedDate: "11 septembre 2025"
summary: "Conditions : Cachexia; Cancer Interventions : Drug: Active Comparator; Drug: ASCA101 24.32mg/kg; Drug: ASCA101 32.43mg/kg; Drug: Placebo Sponsors : MetaFines Not yet recruiting"
importance: ""
sourceUrl: "https://clinicaltrials.gov/study/NCT07168226?term=interventional+radiology&aggFilters=status%3A"
tags: ["France", "Actualité", "ClinicalTrials.gov — ta recherche"]
permalink: "/papers/2025-09-11-phase-2-cachexia-clinical-trial-to-evaluate-the-efficacy-and-safety-of-asca101"
imageUrl: ""
imageCredit: ""
---

## L’essentiel

Conditions : Cachexia; Cancer Interventions : Drug: Active Comparator; Drug: ASCA101 24.32mg/kg; Drug: ASCA101 32.43mg/kg; Drug: Placebo Sponsors : MetaFines Not yet recruiting

## Lien source

https://clinicaltrials.gov/study/NCT07168226?term=interventional+radiology&aggFilters=status%3A
